Racial differences in the distribution of systemic sclerosis-related serum antinuclear antibodies.
about
Prevalence of anti-RNA polymerase III antibodies in systemic sclerosis: New data from a French cohort and a systematic review and meta-analysisSystemic sclerosis: commonly asked questions by rheumatologistsIdentification of an immunodominant epitope on RNA polymerase III recognized by systemic sclerosis sera: application to enzyme-linked immunosorbent assayInfluence of ethnic background on clinical and serologic features in patients with systemic sclerosis and anti-DNA topoisomerase I antibody.Detection of anti-U3-RNP/fibrillarin IgG antibodies by line immunoblot assay has comparable clinical significance to immunoprecipitation testing in systemic sclerosis.Anti-fibrillarin antibody in African American patients with systemic sclerosis: immunogenetics, clinical features, and survival analysis.T cell proliferative response induced by DNA topoisomerase I in patients with systemic sclerosis and healthy donorsAnti-nuclear autoantibodies: clinical utility for diagnosis, prognosis, monitoring, and planning of treatment strategy in systemic immunoinflammatory diseases.The clinical relevance of serum antinuclear antibodies in Japanese patients with systemic sclerosis.A Unique Presentation of Anti-RNA Polymerase III Positive Systemic Sclerosis Sine SclerodermaA case of renal crisis in a Korean scleroderma patient with anti-RNA polymerase I and III antibodies.The role of B cells in systemic sclerosis.The Clinical Relevance of Antifibrillarin (anti-U3-RNP) Autoantibodies in Systemic Sclerosis.Clinical Trial Design Issues in Systemic Sclerosis: an Update.Anti-RNA polymerase III antibodies in patients with systemic sclerosis detected by indirect immunofluorescence and ELISA.Prevalence of anti-histone antibodies, their clinical significance and correlation with other autoantibodies in a cohort of Italian scleroderma patients.Autoantibodies in scleroderma and their association with the clinical profile of the disease. A study of 66 patients from southern Brazil.High incidence of pulmonary arterial hypertension in systemic sclerosis patients with anti-centriole autoantibodies.Autoantibodies in systemic sclerosis.Clinical significance of antinuclear antibodies in systemic rheumatic diseases.RNA polymerase III autoantibodies may indicate renal and more severe skin involvement in systemic sclerosis.HLA class II genes associated with anticentromere antibody in Japanese patients with systemic sclerosis (scleroderma).Immunoglobulin allotype gene polymorphisms in systemic sclerosis: interactive effect of MHC class II and KM genes on anticentromere antibody production.Identification of myocardial damage in systemic sclerosis: a nuclear cardiology approach.Detection of anti-topoisomerase I autoantibody in patients with silicosis.Increased prevalence of autoantibodies to ku antigen in African American versus white patients with systemic lupus erythematosus.Distinctive autoantibody profile in Mexican Mestizo systemic sclerosis patients.Gastric antral vascular ectasia (GAVE) associated with systemic sclerosis.Classification of Japanese patients with mild/early systemic sclerosis (SSc) by the 2013 ACR/EULAR classification criteria for SSc.Clinical and serological features of systemic sclerosis in a multicenter African American cohort: Analysis of the genome research in African American scleroderma patients clinical database.Autoantibodies to RuvBL1 and RuvBL2: a novel systemic sclerosis-related antibody associated with diffuse cutaneous and skeletal muscle involvement.Child-onset systemic sclerosis positive for anticentromere antibodies: two Japanese cases.Reply: To PMID 25512203.Uncommon patterns of antinuclear antibodies recognizing mitotic spindle apparatus antigens and clinical associations
P2860
Q27000819-1303995B-E023-4A9C-8697-E5196EB7841CQ27021067-DE31E050-89FB-4AC5-AAFB-8C5D8C89FD06Q28208168-04AA2B06-8BD9-4081-B674-31658FE2CD18Q33855883-3DD443C8-E674-4635-9C9D-9CCABE5BD681Q34045145-FE558D18-7E19-4A23-9ADF-50C5924DFE6FQ35146164-EA8BFD12-D062-414B-ADFE-C740996C40D0Q35751372-BBF77D4C-BCF4-4610-83A0-9DA17780F5DCQ36272782-9FDEE3A2-7028-4982-AE4D-9EB3090A02ADQ36592069-F0F475BC-1615-4E37-A711-674EFB866A95Q37172044-94693859-D814-4542-94B5-2F69342068E1Q37292117-FB8527B1-FF6B-4FEB-9F33-7E79DF3A2609Q37586886-E54BCC93-D4EA-4400-A5AC-CDF7A09AA850Q38730172-90415C46-1E7D-4A6A-9E51-6ED644ED85ECQ38825869-6F9AE429-EA0B-4572-8C90-6ADB97225463Q39230829-F0CEADD8-FAA6-43F6-B556-D759849771FEQ39366363-3F55198A-4266-48CD-B437-497D5DB3C093Q40018267-C8A2539E-2FF1-450E-8FC5-14DA5B21A262Q40151676-DBF84B50-8B00-4F51-B173-62A902F8B5F6Q40468520-13636CE7-F3B4-48F7-99EA-4C3B5DA07F86Q41156101-2CEF9836-A783-40CC-B953-6F53D5A34635Q41187671-ED1BEF37-564C-48D9-8C2D-46138278F174Q41471335-68EDA52B-549A-48A9-8399-D98A837CC7D2Q42100406-6A2CB351-8E34-4FA2-9ADB-0A2E7D205F73Q42426737-9B9D49D8-5C62-4983-9656-30718DB5B790Q42791824-8AC8D670-8EBB-4999-BE3F-AD649650A723Q46348394-9A5A5B5F-9D92-4E08-8B38-B3DFDDBDD268Q46397634-5ABDCDFE-5215-4AA0-AE8D-0EEC78417D77Q46493999-9B6F344E-15CA-45A3-B9B9-8401A2C97F59Q47634882-0F858764-4369-443E-8F01-E248FD41A1C1Q49486890-D04DF681-3F35-4856-A202-A20B51A59BB9Q50774790-2DB10EC0-395D-4BFA-A07D-27DFE0FC679AQ51283677-8090CB8F-FAF5-433C-80E5-9BC988934D1FQ54271316-ECCEBBC6-6071-456E-BC46-7333C05A27D3Q58706864-4D4E8E0B-D5DE-4AB6-8575-665978ACD89D
P2860
Racial differences in the distribution of systemic sclerosis-related serum antinuclear antibodies.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh-hant
name
Racial differences in the dist ...... serum antinuclear antibodies.
@en
Racial differences in the dist ...... serum antinuclear antibodies.
@nl
type
label
Racial differences in the dist ...... serum antinuclear antibodies.
@en
Racial differences in the dist ...... serum antinuclear antibodies.
@nl
prefLabel
Racial differences in the dist ...... serum antinuclear antibodies.
@en
Racial differences in the dist ...... serum antinuclear antibodies.
@nl
P2093
P356
P1476
Racial differences in the dist ...... serum antinuclear antibodies.
@en
P2093
P304
P356
10.1002/ART.1780370619
P577
1994-06-01T00:00:00Z